Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice.

Diabetes - 1 Jun 1996

Hultgren B, Huang X, Dybdal N, Stewart T A

Abstract excerpt

Cytokines, particularly interferons, may participate in the development of type I diabetes. This involvement could be from direct cytotoxic actions of the interferons on the pancreatic beta-cells or from an indirect influence on the number, activity, or type of inflammatory cells that invade the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aging
Share to Diabetes Mellitus, Type 1
Share to Gene Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression

Share to Genotype

Share to Mice, Mutant Strains

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 8635658
DOI: 10.2337/diab.45.6.812

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-8635658-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic absence of gamma-interferon delays but does not prevent diabetes in NOD mice.PMID 8635658Read ↗

Interferon-gamma receptor signaling is dispensable in the development of autoimmune type 1 diabetes in NOD mice.Semantic proximity Read ↗

Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoimmune diabetes in male NOD mice.Semantic proximity Read ↗

IFN-gamma overexpression within the pancreas is not sufficient to rescue Pax4, Pax6, and Pdx-1 mutant mice from death.Semantic proximity Read ↗

IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice.Semantic proximity Read ↗

Interleukin-4 deficiency does not exacerbate disease in NOD mice.Semantic proximity Read ↗

Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD MouseSemantic proximity Read ↗

NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes.Semantic proximity Read ↗

A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Blockade of the programmed death-1 (PD1) pathway undermines potent genetic protection from type 1 diabetes.Semantic proximity Read ↗

Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice.Semantic proximity Read ↗

IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice.Semantic proximity Read ↗

Molecular analysis of the pathogenesis of autoimmune insulitis in NOD mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.